 Paul Buehler
Concepts (485)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobins | 67 | 2026 | 386 | 10.590 |
Why?
| | Anemia, Sickle Cell | 22 | 2026 | 318 | 4.490 |
Why?
| | Haptoglobins | 26 | 2026 | 71 | 4.300 |
Why?
| | Hemopexin | 12 | 2025 | 38 | 3.490 |
Why?
| | Erythrocytes | 27 | 2026 | 751 | 3.130 |
Why?
| | Oxygen | 27 | 2025 | 986 | 3.130 |
Why?
| | Hemolysis | 23 | 2026 | 242 | 2.740 |
Why?
| | Blood Substitutes | 15 | 2024 | 27 | 2.620 |
Why?
| | Erythrocyte Transfusion | 9 | 2024 | 227 | 2.000 |
Why?
| | Thrombin | 7 | 2023 | 167 | 1.830 |
Why?
| | Extracellular Vesicles | 3 | 2023 | 171 | 1.790 |
Why?
| | Heme | 15 | 2025 | 89 | 1.750 |
Why?
| | Guinea Pigs | 23 | 2024 | 160 | 1.690 |
Why?
| | Cation Transport Proteins | 4 | 2026 | 118 | 1.590 |
Why?
| | Iron | 18 | 2025 | 359 | 1.530 |
Why?
| | Fibrinolysin | 4 | 2022 | 19 | 1.440 |
Why?
| | Homeostasis | 3 | 2020 | 639 | 1.350 |
Why?
| | Transferrin | 5 | 2025 | 50 | 1.350 |
Why?
| | Kidney | 13 | 2020 | 1498 | 1.300 |
Why?
| | Oxidation-Reduction | 26 | 2020 | 1080 | 1.210 |
Why?
| | Hypertension, Pulmonary | 9 | 2026 | 1957 | 1.150 |
Why?
| | Animals | 86 | 2026 | 38141 | 1.140 |
Why?
| | Complement C1 Inhibitor Protein | 4 | 2023 | 12 | 1.120 |
Why?
| | Blood Preservation | 10 | 2023 | 346 | 1.010 |
Why?
| | Blood Transfusion | 6 | 2021 | 408 | 0.980 |
Why?
| | Hypoxia | 8 | 2026 | 1199 | 0.960 |
Why?
| | Oxyhemoglobins | 5 | 2021 | 28 | 0.930 |
Why?
| | Diagnostic Equipment | 1 | 2025 | 5 | 0.920 |
Why?
| | Thrombosis | 4 | 2022 | 401 | 0.900 |
Why?
| | Oximetry | 3 | 2021 | 125 | 0.840 |
Why?
| | Hydrogen Peroxide | 12 | 2021 | 338 | 0.830 |
Why?
| | Electron Spin Resonance Spectroscopy | 7 | 2025 | 96 | 0.800 |
Why?
| | Thrombomodulin | 3 | 2022 | 15 | 0.790 |
Why?
| | Thrombotic Microangiopathies | 2 | 2020 | 19 | 0.770 |
Why?
| | Apoproteins | 3 | 2020 | 15 | 0.750 |
Why?
| | Oxidative Stress | 17 | 2026 | 1350 | 0.750 |
Why?
| | Hypercholesterolemia | 1 | 2023 | 95 | 0.750 |
Why?
| | Drug Design | 3 | 2021 | 176 | 0.690 |
Why?
| | Ascorbic Acid | 6 | 2019 | 175 | 0.690 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 202 | 0.660 |
Why?
| | Nitric Oxide | 11 | 2021 | 894 | 0.660 |
Why?
| | Humans | 98 | 2026 | 145491 | 0.660 |
Why?
| | Antibodies, Bispecific | 1 | 2021 | 69 | 0.650 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 14 | 0.650 |
Why?
| | Hemolytic-Uremic Syndrome | 1 | 2020 | 15 | 0.650 |
Why?
| | Hematologic Diseases | 2 | 2018 | 66 | 0.640 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 7 | 2021 | 65 | 0.620 |
Why?
| | Polymers | 6 | 2024 | 494 | 0.610 |
Why?
| | Recombinant Proteins | 4 | 2021 | 1367 | 0.610 |
Why?
| | Lipids | 3 | 2023 | 709 | 0.600 |
Why?
| | Hemophilia A | 1 | 2021 | 147 | 0.590 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 198 | 0.560 |
Why?
| | Vascular Diseases | 3 | 2024 | 252 | 0.560 |
Why?
| | Receptors, Cell Surface | 7 | 2021 | 372 | 0.540 |
Why?
| | Transfusion Reaction | 3 | 2020 | 61 | 0.530 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4559 | 0.530 |
Why?
| | beta-Thalassemia | 3 | 2025 | 40 | 0.510 |
Why?
| | Lipoproteins | 1 | 2018 | 166 | 0.510 |
Why?
| | Lung | 8 | 2026 | 4103 | 0.500 |
Why?
| | Antigens, CD | 7 | 2021 | 557 | 0.500 |
Why?
| | Macrophages | 7 | 2026 | 1509 | 0.500 |
Why?
| | Biomarkers | 6 | 2020 | 4283 | 0.500 |
Why?
| | Inflammation | 5 | 2026 | 2883 | 0.490 |
Why?
| | Lipid Peroxidation | 8 | 2018 | 163 | 0.470 |
Why?
| | Acute Kidney Injury | 4 | 2018 | 873 | 0.450 |
Why?
| | Hemochromatosis | 1 | 2015 | 9 | 0.440 |
Why?
| | beta-Globins | 1 | 2015 | 8 | 0.440 |
Why?
| | Spleen | 4 | 2025 | 511 | 0.430 |
Why?
| | Vascular Remodeling | 3 | 2026 | 209 | 0.430 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2025 | 34 | 0.420 |
Why?
| | Glutaral | 3 | 2012 | 14 | 0.400 |
Why?
| | Exercise Tolerance | 3 | 2025 | 283 | 0.400 |
Why?
| | Rats, Sprague-Dawley | 10 | 2024 | 2526 | 0.400 |
Why?
| | Mice | 19 | 2026 | 18338 | 0.400 |
Why?
| | Gene Deletion | 1 | 2015 | 392 | 0.390 |
Why?
| | Rats | 15 | 2024 | 5581 | 0.390 |
Why?
| | Peroxidases | 3 | 2015 | 29 | 0.380 |
Why?
| | Male | 44 | 2026 | 72817 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 3897 | 0.370 |
Why?
| | Polyethylene Glycols | 5 | 2024 | 652 | 0.370 |
Why?
| | Models, Animal | 4 | 2020 | 395 | 0.370 |
Why?
| | Receptors, Scavenger | 6 | 2021 | 22 | 0.360 |
Why?
| | Blood Coagulation | 4 | 2022 | 271 | 0.360 |
Why?
| | Cattle | 9 | 2022 | 977 | 0.340 |
Why?
| | Sodium Nitrite | 1 | 2011 | 39 | 0.330 |
Why?
| | Protein Binding | 9 | 2026 | 2250 | 0.330 |
Why?
| | Central Nervous System Diseases | 1 | 2011 | 74 | 0.320 |
Why?
| | Drug Carriers | 2 | 2008 | 134 | 0.310 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2011 | 294 | 0.310 |
Why?
| | Biopolymers | 1 | 2010 | 35 | 0.310 |
Why?
| | Heme Oxygenase-1 | 8 | 2025 | 74 | 0.300 |
Why?
| | Heme Oxygenase (Decyclizing) | 6 | 2013 | 21 | 0.300 |
Why?
| | Biological Transport | 2 | 2021 | 422 | 0.300 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2015 | 141 | 0.300 |
Why?
| | Biological Products | 3 | 2022 | 258 | 0.290 |
Why?
| | Molecular Weight | 6 | 2024 | 312 | 0.290 |
Why?
| | Lung Diseases | 2 | 2015 | 783 | 0.290 |
Why?
| | Erythrocyte Deformability | 2 | 2023 | 23 | 0.290 |
Why?
| | Central Nervous System | 1 | 2011 | 282 | 0.280 |
Why?
| | Hemodynamics | 4 | 2023 | 1116 | 0.280 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 1150 | 0.280 |
Why?
| | Anemia, Hemolytic | 2 | 2026 | 21 | 0.280 |
Why?
| | Amino Acids | 4 | 2021 | 521 | 0.270 |
Why?
| | Liver | 4 | 2025 | 1895 | 0.270 |
Why?
| | Microvessels | 2 | 2020 | 98 | 0.270 |
Why?
| | Erythrocyte Indices | 2 | 2019 | 33 | 0.260 |
Why?
| | Proteome | 3 | 2025 | 517 | 0.260 |
Why?
| | Endothelial Cells | 4 | 2024 | 866 | 0.260 |
Why?
| | Plasma Exchange | 1 | 2007 | 18 | 0.260 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2025 | 70 | 0.260 |
Why?
| | Erythropoiesis | 2 | 2019 | 57 | 0.260 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2019 | 2030 | 0.260 |
Why?
| | Proteomics | 7 | 2025 | 1191 | 0.250 |
Why?
| | Uric Acid | 1 | 2008 | 167 | 0.250 |
Why?
| | Signal Transduction | 4 | 2019 | 5202 | 0.250 |
Why?
| | Extracorporeal Circulation | 1 | 2026 | 14 | 0.240 |
Why?
| | Myocardium | 4 | 2019 | 932 | 0.240 |
Why?
| | Blood Circulation | 1 | 2005 | 44 | 0.230 |
Why?
| | Methemoglobin | 4 | 2021 | 24 | 0.220 |
Why?
| | Circular Dichroism | 2 | 2021 | 144 | 0.220 |
Why?
| | Chromatography, Gel | 5 | 2010 | 128 | 0.220 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 601 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Antioxidants | 1 | 2008 | 549 | 0.210 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 5989 | 0.210 |
Why?
| | Riboflavin | 1 | 2024 | 15 | 0.210 |
Why?
| | Vasoconstriction | 4 | 2020 | 216 | 0.210 |
Why?
| | Vascular Resistance | 2 | 2016 | 369 | 0.210 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 54 | 0.210 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2023 | 24 | 0.200 |
Why?
| | Aspirin | 2 | 2006 | 407 | 0.200 |
Why?
| | Nails | 1 | 2023 | 14 | 0.200 |
Why?
| | Equipment Design | 1 | 2025 | 532 | 0.200 |
Why?
| | Hemoglobin A | 4 | 2006 | 21 | 0.200 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 130 | 0.200 |
Why?
| | Muscle, Skeletal | 3 | 2025 | 1794 | 0.190 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 951 | 0.190 |
Why?
| | Blood Pressure | 6 | 2018 | 1782 | 0.190 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 242 | 0.180 |
Why?
| | Perfusion | 1 | 2024 | 249 | 0.180 |
Why?
| | Protein Engineering | 2 | 2018 | 123 | 0.180 |
Why?
| | Species Specificity | 2 | 2020 | 573 | 0.180 |
Why?
| | Radiation Injuries | 1 | 2023 | 149 | 0.180 |
Why?
| | Superoxides | 1 | 2022 | 199 | 0.180 |
Why?
| | Receptors, Thrombin | 1 | 2022 | 13 | 0.180 |
Why?
| | Receptor, PAR-1 | 1 | 2022 | 17 | 0.180 |
Why?
| | Mycoplasma hyorhinis | 1 | 2021 | 1 | 0.180 |
Why?
| | Intestinal Absorption | 1 | 2002 | 103 | 0.170 |
Why?
| | Methemoglobinemia | 2 | 2015 | 13 | 0.170 |
Why?
| | Fibrinolysis | 2 | 2022 | 164 | 0.170 |
Why?
| | Magnetics | 1 | 2021 | 47 | 0.170 |
Why?
| | Blood Coagulation Tests | 1 | 2021 | 70 | 0.170 |
Why?
| | Cell Line | 6 | 2015 | 2823 | 0.170 |
Why?
| | Ultraviolet Rays | 1 | 2024 | 384 | 0.170 |
Why?
| | Methemalbumin | 1 | 2021 | 1 | 0.170 |
Why?
| | Photoelectron Spectroscopy | 1 | 2021 | 6 | 0.170 |
Why?
| | Factor VIII | 1 | 2021 | 105 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.170 |
Why?
| | Models, Biological | 4 | 2018 | 1815 | 0.170 |
Why?
| | Pulmonary Artery | 3 | 2019 | 1127 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.160 |
Why?
| | Free Radicals | 4 | 2015 | 110 | 0.160 |
Why?
| | Antifibrinolytic Agents | 1 | 2021 | 64 | 0.160 |
Why?
| | Tranexamic Acid | 1 | 2021 | 59 | 0.160 |
Why?
| | Polymerization | 3 | 2023 | 130 | 0.160 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 33 | 0.160 |
Why?
| | Hypertension | 3 | 2020 | 1273 | 0.160 |
Why?
| | Beta vulgaris | 1 | 2020 | 14 | 0.160 |
Why?
| | Lung Transplantation | 1 | 2024 | 330 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2002 | 170 | 0.160 |
Why?
| | CD40 Antigens | 1 | 2021 | 89 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 82 | 0.160 |
Why?
| | Subarachnoid Space | 1 | 2019 | 8 | 0.160 |
Why?
| | Vasospasm, Intracranial | 1 | 2019 | 19 | 0.150 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 72 | 0.150 |
Why?
| | Protein Unfolding | 1 | 2019 | 32 | 0.150 |
Why?
| | Blotting, Western | 5 | 2015 | 1162 | 0.150 |
Why?
| | Biotechnology | 1 | 2019 | 46 | 0.150 |
Why?
| | Spin Labels | 2 | 2025 | 59 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2019 | 69 | 0.150 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 104 | 0.150 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 37 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 71 | 0.150 |
Why?
| | Ferritins | 2 | 2010 | 70 | 0.150 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 327 | 0.150 |
Why?
| | Equipment and Supplies | 1 | 2019 | 36 | 0.140 |
Why?
| | Osmotic Fragility | 2 | 2024 | 12 | 0.140 |
Why?
| | Nitrates | 2 | 2020 | 100 | 0.140 |
Why?
| | Toxicokinetics | 1 | 2018 | 8 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 343 | 0.140 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2594 | 0.140 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 43 | 0.140 |
Why?
| | Erythropoietin | 2 | 2018 | 100 | 0.140 |
Why?
| | Female | 18 | 2026 | 78763 | 0.140 |
Why?
| | Cell Communication | 1 | 2020 | 326 | 0.140 |
Why?
| | Antibodies | 1 | 2021 | 398 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2019 | 218 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 667 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 187 | 0.140 |
Why?
| | Fibrin | 1 | 2019 | 84 | 0.140 |
Why?
| | Lipocalin-2 | 1 | 2018 | 80 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2018 | 156 | 0.140 |
Why?
| | Plasma | 1 | 2020 | 225 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 190 | 0.130 |
Why?
| | Metabolic Clearance Rate | 2 | 2012 | 115 | 0.130 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 325 | 0.130 |
Why?
| | Models, Cardiovascular | 1 | 2019 | 197 | 0.130 |
Why?
| | Liver Diseases | 1 | 2021 | 304 | 0.130 |
Why?
| | Neutrophil Activation | 1 | 2018 | 84 | 0.130 |
Why?
| | Hepcidins | 2 | 2015 | 21 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2018 | 975 | 0.130 |
Why?
| | Temperature | 1 | 2021 | 681 | 0.130 |
Why?
| | Physical Exertion | 1 | 2018 | 205 | 0.130 |
Why?
| | Serine Endopeptidases | 1 | 2018 | 129 | 0.130 |
Why?
| | Solutions | 2 | 2010 | 166 | 0.130 |
Why?
| | Oxymorphone | 1 | 2016 | 5 | 0.130 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 207 | 0.120 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 37 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 342 | 0.120 |
Why?
| | Metabolomics | 4 | 2025 | 729 | 0.120 |
Why?
| | Dogs | 3 | 2022 | 438 | 0.120 |
Why?
| | Proteins | 1 | 2023 | 1020 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 654 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2019 | 11831 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1769 | 0.120 |
Why?
| | Swine | 4 | 2021 | 833 | 0.120 |
Why?
| | Microcirculation | 2 | 2020 | 142 | 0.120 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2018 | 106 | 0.110 |
Why?
| | Sepsis | 2 | 2020 | 661 | 0.110 |
Why?
| | Spin Trapping | 1 | 2015 | 3 | 0.110 |
Why?
| | Cardiac Surgical Procedures | 1 | 2021 | 613 | 0.110 |
Why?
| | Disease Progression | 3 | 2023 | 2862 | 0.110 |
Why?
| | Heart | 1 | 2019 | 626 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 389 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 994 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 383 | 0.110 |
Why?
| | Protein Stability | 3 | 2012 | 178 | 0.110 |
Why?
| | Splenomegaly | 1 | 2015 | 15 | 0.110 |
Why?
| | Muscle Contraction | 1 | 2018 | 430 | 0.110 |
Why?
| | Procollagen-Proline Dioxygenase | 2 | 2011 | 27 | 0.110 |
Why?
| | Tissue Distribution | 2 | 2025 | 335 | 0.110 |
Why?
| | Cardiac Output | 2 | 2012 | 179 | 0.110 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 149 | 0.100 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 566 | 0.100 |
Why?
| | Prostatic Neoplasms | 1 | 2021 | 978 | 0.100 |
Why?
| | Altitude | 1 | 2018 | 473 | 0.100 |
Why?
| | Cell-Free System | 3 | 2011 | 53 | 0.100 |
Why?
| | Hemorrhage | 1 | 2019 | 826 | 0.100 |
Why?
| | Mesocricetus | 2 | 2026 | 49 | 0.100 |
Why?
| | Excipients | 2 | 2024 | 55 | 0.100 |
Why?
| | Endotoxemia | 1 | 2014 | 86 | 0.100 |
Why?
| | Adult | 6 | 2026 | 40707 | 0.100 |
Why?
| | Cross-Linking Reagents | 2 | 2012 | 197 | 0.100 |
Why?
| | Cricetinae | 2 | 2026 | 299 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2015 | 242 | 0.100 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 20 | 0.090 |
Why?
| | Creatinine | 2 | 2012 | 513 | 0.090 |
Why?
| | Reactive Oxygen Species | 2 | 2007 | 602 | 0.090 |
Why?
| | Models, Molecular | 3 | 2020 | 1614 | 0.090 |
Why?
| | Prognosis | 1 | 2021 | 4323 | 0.090 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 32 | 0.090 |
Why?
| | Infusion Pumps | 1 | 2012 | 33 | 0.090 |
Why?
| | Membrane Proteins | 3 | 2020 | 1164 | 0.090 |
Why?
| | Malaria | 1 | 2013 | 73 | 0.090 |
Why?
| | Macaca mulatta | 2 | 2025 | 186 | 0.090 |
Why?
| | Exercise | 1 | 2024 | 2192 | 0.090 |
Why?
| | Neutrophils | 1 | 2018 | 1124 | 0.090 |
Why?
| | Transcriptome | 2 | 2018 | 1038 | 0.090 |
Why?
| | Cardio-Renal Syndrome | 1 | 2012 | 20 | 0.090 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2023 | 96 | 0.090 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 368 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1706 | 0.090 |
Why?
| | Dimerization | 2 | 2010 | 190 | 0.090 |
Why?
| | Tyrosine | 1 | 2012 | 219 | 0.090 |
Why?
| | Glycolysis | 2 | 2025 | 342 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 23 | 0.090 |
Why?
| | Cytokines | 2 | 2021 | 2054 | 0.090 |
Why?
| | Occludin | 1 | 2011 | 11 | 0.090 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2011 | 16 | 0.090 |
Why?
| | Cohort Studies | 2 | 2021 | 5992 | 0.090 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 17 | 0.090 |
Why?
| | Surface Plasmon Resonance | 2 | 2008 | 88 | 0.080 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 81 | 0.080 |
Why?
| | Area Under Curve | 1 | 2012 | 329 | 0.080 |
Why?
| | Claudins | 1 | 2011 | 22 | 0.080 |
Why?
| | Basilar Artery | 2 | 2021 | 7 | 0.080 |
Why?
| | Heart Diseases | 1 | 2014 | 342 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3619 | 0.080 |
Why?
| | Erythrocyte Aggregation | 1 | 2010 | 4 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1478 | 0.080 |
Why?
| | Filtration | 1 | 2010 | 71 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 157 | 0.080 |
Why?
| | Biophysics | 1 | 2010 | 76 | 0.070 |
Why?
| | Oxygen Consumption | 2 | 2024 | 718 | 0.070 |
Why?
| | Fatty Acids | 2 | 2023 | 459 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 410 | 0.070 |
Why?
| | Pyridones | 1 | 2011 | 208 | 0.070 |
Why?
| | Aorta | 1 | 2012 | 439 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2011 | 339 | 0.070 |
Why?
| | Pneumonia | 1 | 2015 | 632 | 0.070 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2008 | 9 | 0.070 |
Why?
| | Globins | 1 | 2008 | 21 | 0.070 |
Why?
| | alpha-Globins | 1 | 2008 | 9 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2015 | 4127 | 0.070 |
Why?
| | Cellular Senescence | 1 | 2011 | 225 | 0.070 |
Why?
| | Buffers | 1 | 2008 | 55 | 0.070 |
Why?
| | Hemin | 2 | 2021 | 4 | 0.070 |
Why?
| | Lasers | 2 | 2005 | 128 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2017 | 444 | 0.070 |
Why?
| | Ferric Compounds | 1 | 2008 | 54 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2189 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 207 | 0.070 |
Why?
| | Drug Stability | 1 | 2007 | 169 | 0.060 |
Why?
| | Tissue Engineering | 1 | 2011 | 441 | 0.060 |
Why?
| | Binding Sites | 2 | 2011 | 1313 | 0.060 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 503 | 0.060 |
Why?
| | Cell Tracking | 1 | 2026 | 19 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 162 | 0.060 |
Why?
| | Pentetic Acid | 1 | 2005 | 13 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2018 | 339 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 567 | 0.060 |
Why?
| | Molecular Structure | 1 | 2007 | 498 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 445 | 0.060 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 116 | 0.060 |
Why?
| | Raffinose | 1 | 2005 | 29 | 0.060 |
Why?
| | Cysteine | 1 | 2006 | 208 | 0.060 |
Why?
| | Cystine | 1 | 2005 | 17 | 0.060 |
Why?
| | Coronary Vessels | 2 | 2018 | 247 | 0.060 |
Why?
| | Scattering, Radiation | 1 | 2005 | 99 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2373 | 0.050 |
Why?
| | Child | 2 | 2023 | 22680 | 0.050 |
Why?
| | Time Factors | 2 | 2015 | 7171 | 0.050 |
Why?
| | Kinetics | 1 | 2008 | 1605 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2021 | 743 | 0.050 |
Why?
| | Peptides | 1 | 2010 | 993 | 0.050 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2024 | 9 | 0.050 |
Why?
| | Chlorides | 1 | 2005 | 142 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2017 | 2499 | 0.050 |
Why?
| | Phenotype | 2 | 2026 | 3157 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 188 | 0.050 |
Why?
| | Fish Oils | 1 | 2023 | 26 | 0.050 |
Why?
| | Particle Size | 1 | 2005 | 402 | 0.050 |
Why?
| | Acute Disease | 2 | 2021 | 1040 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 264 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 859 | 0.050 |
Why?
| | Allografts | 1 | 2024 | 153 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 296 | 0.050 |
Why?
| | Piperidines | 1 | 2004 | 221 | 0.050 |
Why?
| | Cercopithecidae | 1 | 2002 | 8 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2004 | 515 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2024 | 1047 | 0.040 |
Why?
| | Drug Compounding | 1 | 2022 | 107 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2022 | 171 | 0.040 |
Why?
| | Protein Conformation | 1 | 2005 | 935 | 0.040 |
Why?
| | Hand | 1 | 2023 | 161 | 0.040 |
Why?
| | Risk Assessment | 1 | 2012 | 3759 | 0.040 |
Why?
| | Biological Availability | 1 | 2002 | 144 | 0.040 |
Why?
| | Serum Albumin, Human | 1 | 2021 | 6 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2022 | 99 | 0.040 |
Why?
| | Young Adult | 1 | 2018 | 14192 | 0.040 |
Why?
| | Cell Survival | 2 | 2018 | 1094 | 0.040 |
Why?
| | Platelet Activation | 1 | 2022 | 98 | 0.040 |
Why?
| | Etanercept | 1 | 2021 | 60 | 0.040 |
Why?
| | Nitrites | 2 | 2013 | 89 | 0.040 |
Why?
| | Horses | 1 | 2022 | 227 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 55 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 91 | 0.040 |
Why?
| | Cell Movement | 1 | 2005 | 961 | 0.040 |
Why?
| | Kynurenine | 1 | 2021 | 103 | 0.040 |
Why?
| | ADAMTS13 Protein | 1 | 2020 | 7 | 0.040 |
Why?
| | Triage | 1 | 2023 | 252 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 249 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 296 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 573 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 536 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 2002 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 175 | 0.040 |
Why?
| | von Willebrand Factor | 1 | 2020 | 85 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 36176 | 0.040 |
Why?
| | Cardiopulmonary Bypass | 1 | 2021 | 217 | 0.040 |
Why?
| | Blood Banks | 1 | 2019 | 50 | 0.040 |
Why?
| | Administration, Oral | 1 | 2002 | 863 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 306 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 144 | 0.040 |
Why?
| | Cerebrospinal Fluid | 1 | 2019 | 88 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2019 | 62 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2019 | 149 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 84 | 0.040 |
Why?
| | Transfection | 1 | 2021 | 925 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 187 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 581 | 0.040 |
Why?
| | Intracranial Aneurysm | 1 | 2019 | 105 | 0.040 |
Why?
| | Endothelins | 1 | 2018 | 61 | 0.030 |
Why?
| | Blood Platelets | 1 | 2022 | 380 | 0.030 |
Why?
| | Tissue Donors | 1 | 2021 | 421 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 248 | 0.030 |
Why?
| | Blood Safety | 1 | 2017 | 11 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2021 | 505 | 0.030 |
Why?
| | Vasodilation | 1 | 2021 | 521 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2018 | 67 | 0.030 |
Why?
| | Hemodilution | 2 | 2008 | 11 | 0.030 |
Why?
| | Viscosity | 1 | 2018 | 93 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.030 |
Why?
| | Precision Medicine | 1 | 2022 | 456 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 850 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2137 | 0.030 |
Why?
| | Metabolome | 1 | 2020 | 387 | 0.030 |
Why?
| | Sheep | 1 | 2019 | 882 | 0.030 |
Why?
| | Acclimatization | 1 | 2018 | 172 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1733 | 0.030 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 2006 | 19 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2020 | 580 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1049 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1896 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2016 | 187 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 590 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 2060 | 0.030 |
Why?
| | Electric Impedance | 1 | 2015 | 110 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 79 | 0.030 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2015 | 100 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 754 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 579 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 353 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2820 | 0.030 |
Why?
| | Apoptosis | 2 | 2014 | 2411 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 427 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 383 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2945 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2425 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2017 | 772 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2013 | 119 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 159 | 0.020 |
Why?
| | Mitochondria | 1 | 2019 | 990 | 0.020 |
Why?
| | Phagocytosis | 1 | 2014 | 297 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2011 | 6 | 0.020 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 21 | 0.020 |
Why?
| | Deferoxamine | 1 | 2011 | 27 | 0.020 |
Why?
| | Siderophores | 1 | 2011 | 13 | 0.020 |
Why?
| | Hydroxylation | 1 | 2011 | 49 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2011 | 115 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 88 | 0.020 |
Why?
| | Cobalt | 1 | 2011 | 52 | 0.020 |
Why?
| | DNA Damage | 1 | 2014 | 434 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1755 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 667 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 563 | 0.020 |
Why?
| | Bioreactors | 1 | 2011 | 51 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 366 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2910 | 0.020 |
Why?
| | Tight Junctions | 1 | 2011 | 82 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 125 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 855 | 0.020 |
Why?
| | Hemoglobinuria | 1 | 2010 | 5 | 0.020 |
Why?
| | Glucose Oxidase | 1 | 2010 | 25 | 0.020 |
Why?
| | Caspase 3 | 1 | 2011 | 234 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3125 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2010 | 200 | 0.020 |
Why?
| | Nitroso Compounds | 1 | 2009 | 6 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2009 | 19 | 0.020 |
Why?
| | Blood Component Transfusion | 1 | 2010 | 104 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 230 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 8039 | 0.020 |
Why?
| | Canada | 1 | 2010 | 434 | 0.020 |
Why?
| | Glutathione | 1 | 2010 | 366 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 266 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 751 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 234 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 248 | 0.020 |
Why?
| | Heart Failure | 1 | 2021 | 2329 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2944 | 0.020 |
Why?
| | Peroxides | 1 | 2006 | 19 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 890 | 0.020 |
Why?
| | Erythrocyte Membrane | 1 | 2006 | 54 | 0.020 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2005 | 15 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2005 | 41 | 0.010 |
Why?
| | Rabbits | 1 | 2006 | 651 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2009 | 531 | 0.010 |
Why?
| | Endocytosis | 1 | 2005 | 168 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 374 | 0.010 |
Why?
| | Endosomes | 1 | 2005 | 140 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1468 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 693 | 0.010 |
Why?
| | United States | 1 | 2017 | 16115 | 0.010 |
Why?
|
|
Buehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|